Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision.
Emely AI has raised $512K in total funding. The most recent round was Pre-Seed. The last funding was announced in April 2024.
Emely AI's investors include BStartup.
Emely AI is headquartered in New York, United States.
Emily.AI enables the adaptation to various environments and patient conditions, reducing or eliminating the need for medical supervision.
Emely AI is at the Pre-Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Emely AI — Funding & Investors." VCBacked, April 13, 2024, https://www.vcbacked.co/company/emely-ai. Accessed August 2, 2026.
VCBacked. (2024). Emely AI — Funding & Investors. Retrieved August 2, 2026, from https://www.vcbacked.co/company/emely-ai
{{cite web |title=Emely AI — Funding & Investors |url=https://www.vcbacked.co/company/emely-ai |website=VCBacked |access-date=August 2, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated